Medtronic, Inc. (MDT) PT Lowered to $135 at UBS
Tweet
Share
E-mailGet Alerts MDT Hot Sheet
Price: $90.00 -0.39%
Rating Summary:
16 Buy, 22 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 13 | New: 51
Rating Summary:
16 Buy, 22 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 13 | New: 51
Join SI Premium – FREE
UBS analyst Matthew Taylor lowered the price target on Medtronic, Inc. (NYSE: MDT) to $135.00 (from $145.00) while maintaining a Buy rating.
You May Also Be Interested In
- Piper Sandler Reiterates Neutral Rating on Medtronic, Inc. (MDT)
- BofA Securities Downgrades Fulcrum Therapeutics (FULC) to Underperform
- Warner Music Group (WMG) PT Raised to $44 at Tigress Financial Partners, 'potential return with dividends of over 60% from current levels'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
